nimacimab glp-1 news Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch Skye Bioscience Q2 2025 slides:

The Phase 2 trial , published in the New England Journal of Medicine, tested doses from 1 mg to 12 mg over 48 weeks

So, we built a tool that allows patients to crowdsource and aggregate their efforts, in a structured and fully automated way, and pay it forward," Reitano said

[33] In chronic inflammatory bowel diseases, including Crohns disease, systematic reviews (including Cochrane reviews) have concluded that current randomized evidence is insufficient to support glutamine supplementation for inducing remission or modifying disease progression, and further well-powered clinical trials are required

Endocrinology (2013) 154:355264

Silva provides in-person and virtual care for patients with clinics in Salt Lake City , St

We harbor respect for each other: our individual and combined experiences drive what we pursue